Comparison of reference Infliximab and a Biosimilar (CT-P13) in Crohn ' s Disease (CME/CE)

(MedPage Today) -- Analysis of real-world data show that CT-P13 is equivalent to infliximab in infliximab-naive patients with CD
Source: MedPage Today Gastroenterology - Category: Gastroenterology Source Type: news